Linkage to Care Outcomes Following Treatment in A Low-Threshold Substance Use Disorder Bridge Clinic

被引:0
作者
Casey, Sarah K. [1 ]
Howard, Sydney [2 ]
Regan, Susan [2 ,3 ]
Romero, Alison [1 ]
Powell, Elizabeth A. [1 ]
Kehoe, Laura [2 ,3 ]
Kane, Martha T. [1 ,3 ]
Wakeman, Sarah E. [2 ,3 ]
机构
[1] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA USA
[2] Massachusetts Gen Hosp, Dept Med, 55 Fruit St,Austen 860, Boston, MA 02114 USA
[3] Harvard Med Sch, Boston, MA USA
来源
SUBSTANCE USE & ADDICTION JOURNAL | 2025年 / 46卷 / 02期
关键词
bridge clinic; substance use disorder; cascade of care; opioid use disorder; medication for opioid use disorder; buprenorphine; OPIOID USE DISORDER; HEALTH-CARE; RETENTION; THERAPY; STIGMA; MOBILE;
D O I
10.1177/29767342241261609
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Treatment for substance use disorders (SUD) remains low in the United States. To better meet needs of people who use alcohol and other drugs, low threshold bridge clinics which offer treatment without barrier and harm reduction services have gained prevalence. Bridge clinics work to surmount barriers to care by providing same day medication and treatment for SUD and eventually transitioning patients to community-based treatment providers. In this study, we examine SUD treatment outcomes among patients who transitioned out of a bridge clinic.Methods: This is a retrospective cohort study of posttreatment outcomes of patients seen at an urban medical center's bridge clinic between 2017 and 2022. The primary outcome was being in care anywhere at time of follow-up. We also examined the proportion of patients who completed each step of the cascade of care following transfer: connection to transfer clinic, completion of a clinic visit, retention in care, and medication use among those remaining in care at the transfer clinic. We examined the association of different bridge clinic services with still being in care anywhere and the association between successful transfer with being in care and taking medication at follow-up.Results: Of 209 eligible participants, 63 were surveyed. Sixty-five percent of participants identified as male, 74% as white, 12% as Hispanic, 6% as Black, and 16% were unhoused. Most participants (78%) reported being connected to SUD treatment from the Bridge Clinic, and 37% remained in care at the same facility at the time of survey. Eighty-four percent reported being in treatment anywhere and 68% reported taking medication for SUD at follow-up, with most participants reporting taking buprenorphine (46%).Conclusion: Of those participants who transitioned out of a bridge clinic into community-based SUD care, 78% were successfully connected to ongoing care and 84% were still in care at follow-up.
引用
收藏
页码:247 / 255
页数:9
相关论文
共 45 条
  • [1] [Anonymous], 2021, KEY SUBSTANCE USE ME
  • [2] Aronowitz SV., 2022, Lowering the Barriers to Medication Treatment for People with Opioid Use Disorder: Evidence for a Low-Threshold Approach
  • [3] HIV Exposure Prophylaxis Delivery in a Low-barrier Substance Use Disorder Bridge Clinic during a Local HIV Outbreak at the Onset of the COVID-19 Pandemic
    Braun, Hannan M.
    Walter, Chelsea
    Farrell, Natalija
    Biello, Katie B.
    Taylor, Jessica L.
    [J]. JOURNAL OF ADDICTION MEDICINE, 2022, 16 (06) : 678 - 683
  • [4] Assessing the validity of single-item life satisfaction measures: results from three large samples
    Cheung, Felix
    Lucas, Richard E.
    [J]. QUALITY OF LIFE RESEARCH, 2014, 23 (10) : 2809 - 2818
  • [5] Acute Care Utilization After Recovery Coaching Linkage During Substance-Related Inpatient Admission: Results of Two Randomized Controlled Trials
    Cupp, Julia A.
    Byrne, Kaileigh A.
    Herbert, Kristin
    Roth, Prerana J.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2022, 37 (11) : 2768 - 2776
  • [6] Systematic review and meta-analysis of changes in quality of life following initiation of buprenorphine for opioid use disorder
    Golan, Olivia K.
    Totaram, Rachel
    Perry, Elizabeth
    Fortson, Kennicia
    Rivera-Atilano, Raul
    Entress, Rebecca
    Golan, Matthew
    Andraka-Christou, Barbara
    Whitaker, Daniel
    Pigott, Therese
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2022, 235
  • [7] Impact of Medication-Based Treatment on Health Care Utilization Among Individuals With Opioid Use Disorder
    Gopaldas, Manesh
    Wenzel, Kevin
    Campbell, Aimee N. C.
    Jalali, Ali
    Fishman, Marc
    Rotrosen, John
    V. Nunes, Edward
    Murphy, Sean M.
    [J]. PSYCHIATRIC SERVICES, 2023, 74 (12) : 1227 - 1233
  • [8] Patient retention in mobile and fixed-site methadone maintenance treatment
    Greenfield, L
    Brady, JV
    Besteman, KJ
    DeSmet, A
    [J]. DRUG AND ALCOHOL DEPENDENCE, 1996, 42 (02) : 125 - 131
  • [9] Mobile opioid agonist treatment and public funding expands treatment for disenfranchised opioid-dependent individuals
    Hall, Gerod
    Neighbors, Charles J.
    Iheoma, Jude
    Dauber, Sarah
    Adams, MerriBeth
    Culleton, Robert
    Muench, Fred
    Borys, Suzanne
    McDonald, Rebecca
    Morgenstern, Jon
    [J]. JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2014, 46 (04) : 511 - 515
  • [10] Initiation of opioid agonist therapy after hospital visits for opioid poisonings in Ontario
    Hu, Tina
    Mccormack, Daniel
    Juurlink, David N.
    Campbell, Tonya J.
    Bayoumi, Ahmed M.
    Leece, Pamela
    Kent, Jessica T.
    Gomes, Tara
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2023, 195 (49) : E1709 - E1717